Document Detail


Atherosclerosis and rheumatoid arthritis: more than a simple association.
MedLine Citation:
PMID:  23024462     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the last decades a large amount of evidence linked rheumatoid arthritis (RA) to atherosclerosis. In fact, RA patients have an increased risk of cardiovascular events that is not fully explained by other classic cardiovascular risk factors. RA and atherosclerosis may share several common pathomechanisms and inflammation undoubtedly plays a primary role. The proinflammatory cytokines such as tumor necrosis factor alpha and interleukin-6, involved in the pathogenesis of RA, are also independently predictive of subsequent cardiovascular disease (CVD). In RA, inflammation alters HDL constituents and the concentration of LDL and HDL, thus facilitating atherosclerosis and CVD events. On the other hand, also the increase of oxidative processes, frequently observed in RA, induces atherosclerosis. Interestingly, some genetic polymorphisms associated with RA occurrence enhance atherosclerosis, however, other polymorphisms associated with RA susceptibility do not increase CVD risk. Several other mechanisms may influence atherosclerotic processes in RA. Moreover, atherosclerosis may be directly mediated also by underlying autoimmune processes, and indirectly by the occurrence of metabolic syndrome and impaired physical activity. Finally, the effects of RA therapies on cardiovascular system in general and on atherosclerosis in particular are really wide and different. However, the starting point of every RA treatment is that disease control, or better remission, is the best way we have for the reduction of CVD occurrence.
Authors:
Lorenzo Cavagna; Nicola Boffini; Giovanni Cagnotto; Flora Inverardi; Vittorio Grosso; Roberto Caporali
Publication Detail:
Type:  Journal Article     Date:  2012-09-13
Journal Detail:
Title:  Mediators of inflammation     Volume:  2012     ISSN:  1466-1861     ISO Abbreviation:  Mediators Inflamm.     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-01     Completed Date:  2013-02-04     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  9209001     Medline TA:  Mediators Inflamm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  147354     Citation Subset:  IM    
Affiliation:
Department of Rheumatology, University and IRCCS Foundation Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy. lorenzo.cavagna@unipv.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthritis, Rheumatoid / genetics,  metabolism*
Atherosclerosis / genetics,  metabolism*
Cardiovascular Diseases / genetics,  metabolism*
Cytokines / metabolism
Humans
Chemical
Reg. No./Substance:
0/Cytokines
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Silica-dispersed glucose oxidase for glucose sensing: in vitro testing in serum and blood and the ef...
Next Document:  Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs.